G. Kyselyova

Clinical outcomes in persons coinfected with HIV and HCV: Impact of HCV treatment

R. Haubrich, A. Mocroft, J. Lundgren, 2019, Clinical Infectious Diseases.

Clinical Outcomes in Persons Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus: Impact of Hepatitis C Virus Treatment.

R. Haubrich, A. Mocroft, J. Lundgren, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Incidence of cancer and overall risk of mortality in individuals treated with raltegravir‐based and non‐raltegravir‐based combination antiretroviral therapy regimens

C. Leen, A. Mocroft, O. Kirk, 2017, HIV medicine.

Delayed diagnosis of tuberculosis in persons living with HIV in Eastern Europe: associated factors and effect on mortality—a multicentre prospective cohort study

A. Mocroft, O. Kirk, J. González, 2021, BMC Infectious Diseases.

Antiretrovirals, Fractures, and Osteonecrosis in a Large International HIV Cohort

C. Leen, A. Mocroft, R. Weber, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Abacavir usage patterns and hypersensitivity reactions in the EuroSIDA cohort

A. Mocroft, A. d’Arminio Monforte, A. Clarke, 2018, HIV medicine.

Management of MDR-TB in HIV co-infected patients in Eastern Europe: Results from the TB:HIV study.

A. Mocroft, O. Kirk, A. Schultze, 2018, The Journal of infection.

Changing utilization of Stavudine (d4T) in HIV‐positive people in 2006–2013 in the EuroSIDA study

J. Nielsen, C. Leen, P. Vanhems, 2015, HIV medicine.

Long‐term effectiveness of recommended boosted protease inhibitor‐based antiretroviral therapy in Europe

A. Mocroft, A. Blaxhult, J. Lundgren, 2018, HIV medicine.